Indaptus Therapeutics, Inc. has received Clinical Trial Authorization from Health Canada to expand its U.S. clinical trial of Decoy20, a treatment for cancer and viral infections, into Canadian sites.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results